|Bid||21.53 x 800|
|Ask||21.62 x 3200|
|Day's range||21.45 - 21.97|
|52-week range||17.91 - 25.25|
|Beta (5Y monthly)||1.29|
|PE ratio (TTM)||33.70|
|Earnings date||26 Oct 2023 - 30 Oct 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||24.00|
Alignment Healthcare (ALHC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Avantor's (AVTR) partnership is likely to meet the growing need among biopharma and life science companies for end-to-end solutions.
AVTR, TECH and CPRI have been added to the Zacks Rank #5 (Strong Sell) List on September 11, 2023.